RapidPulse Raises $48 Million Series B To Advance Stroke Aspiration Technology

RapidPulse, a Miami-based medical device company, closed a $48 million Series B funding round co-led by Medtronic, TechWald Next, and S3 Ventures to advance its stroke treatment technology. The capital will fund completion of the TURBO clinical trial and support FDA approval efforts for RapidPulse's pulsed aspiration system, designed to remove blood clots in acute ischemic stroke patients. The round also included investments from SBI Investment Company and Florida Opportunity Fund alongside previous backers.